Patent assignee · FR · COMPANY

Effimune

2Patents
2Active
2Granted
37Portfolio score

Filing activity: Oct 8, 2010 → Feb 16, 2011 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8785604B2 Anti-CD28 humanized antibodies Chemistry; Metallurgy 3 Active
US8785138B2 Monovalent ligands of the human CD28 receptor Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.